Detected ·
Specific Biologics
$35M—
Specific Biologics raised US$35M to advance its Dualase gene-editing technology targeting ALS and other repeat expansion disorders, with first human studies anticipated in 2028.
- Website
- —
- linkedin.com/company/18991581
- Amount
- $35 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-11-04 00:08:24 UTC
- Signal ID
- 90209413-ab57-4f49-9ce1-cfb86ee6235b
As the API returns it
{
"id": "90209413-ab57-4f49-9ce1-cfb86ee6235b",
"created_at": "2026-11-04T00:08:24.166071Z",
"company_name": "Specific Biologics",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/18991581",
"event_type": "funding",
"funding_amount": 35000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Specific Biologics raised US$35M to advance its Dualase gene-editing technology targeting ALS and other repeat expansion disorders, with first human studies anticipated in 2028.*"
}